The benefits of adefovir dipivoxil for HBeAg-negative chronic hepatitis B did not persist after discontinuation of treatment
- PMID: 16388554
The benefits of adefovir dipivoxil for HBeAg-negative chronic hepatitis B did not persist after discontinuation of treatment
Comment on
-
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.N Engl J Med. 2005 Jun 30;352(26):2673-81. doi: 10.1056/NEJMoa042957. N Engl J Med. 2005. PMID: 15987916 Clinical Trial.